NeuroHELP

Company Overview

Snapshot

Founded in January 2018 by Nadav Karni, Oren Shriki, Hadar Ron, and Shay Ben Sasson, NeuroHELP operates with 11–50 employees. The company is currently in the Pre-Funding stage, developing advanced neurotechnology. A significant milestone for the company was the development of a device that predicts epileptic seizures by researchers at Ben-Gurion University, as reported in September 2020.

Business overview

NeuroHELP is a Health Tech & Life Sciences company focused on developing portable neurotechnology for forecasting epileptic seizures. The company's core product is a simple, portable EEG system designed for daily use by epilepsy patients. This system utilizes algorithmic solutions, including automatic signal preprocessing, artifact removal, advanced nonlinear measures of brain activity, and machine learning techniques to assess the likelihood of an upcoming seizure. NeuroHELP serves the healthcare industry, specifically targeting patients with epilepsy and their caregivers, with the goal of improving quality of life by providing advance warning of seizures and assisting in optimizing drug treatments.

Strategic signal

In September 2020, researchers at Ben-Gurion University developed a device capable of predicting epileptic seizures, a technology central to NeuroHELP's mission. This development is a strong signal of the company's foundational scientific validation and potential to bring a significant advancement to epilepsy management, offering a proactive approach to patient care and potentially reducing the anxiety associated with unpredictable seizures.

Company Intelligence Q&A

What is NeuroHELP's primary focus?

NeuroHELP is focused on developing portable neurotechnology designed to forecast epileptic seizures, aiming to provide advance alerts to patients and caregivers.

When was NeuroHELP founded and by whom?

NeuroHELP was founded in January 2018 by Nadav Karni, Oren Shriki, Hadar Ron, and Shay Ben Sasson.

What is the core technology behind NeuroHELP's system?

The core technology involves algorithmic solutions for signal preprocessing, artifact removal, advanced nonlinear measures of brain activity, and machine learning techniques to predict seizures.

What was a significant early development for NeuroHELP?

In September 2020, researchers at Ben-Gurion University developed a device that predicts epileptic seizures, which is a key component of NeuroHELP's technology.

What problem does NeuroHELP aim to solve for epilepsy patients?

NeuroHELP aims to improve the quality of life for individuals with epilepsy by reducing anxiety caused by unpredictable seizures and allowing for advance preparation, as well as assisting in optimizing drug treatments.